Skip to main content
Transactions of the Royal Society of Tropical Medicine and Hygiene logoLink to Transactions of the Royal Society of Tropical Medicine and Hygiene
. 2017 Jun 28;111(4):185–187. doi: 10.1093/trstmh/trx031

Gastrointestinal tract involvement in melioidosis

Prapit Teparrukkul 1, Worrarat Kongkasame 1, Songla Chitsaeng 1, Gumphol Wongsuwan 2, Vanaporn Wuthiekanun 2, Sharon J Peacock 2,3,4, Direk Limmathurotsakul 2,5,6,*
PMCID: PMC6092629  PMID: 28673019

Abstract

Background

Little is known about the involvement of the human gut in carriage and disease associated with Burkholderia pseudomallei, the cause of melioidosis.

Methods

A hospital-based study was conducted in Northeast Thailand to culture stools or rectal swabs from patients with melioidosis, stools from controls with non-infectious diseases, and gastric biopsies from patients undergoing routine endoscopic investigation.

Results and Conclusion

B. pseudomallei was isolated from 9/83 (11%) stools and 9/58 (16%) rectal swabs from 141 patients with melioidosis. All stools from 244 control patients and 799 gastric biopsies from 395 patients with no evidence of melioidosis were culture negative for B. pseudomallei. It is not uncommon for melioidosis patients to shed B. pseudomallei in stool. Colonization of the gut of individuals without signs and symptoms of melioidosis may be rare.

Keywords: Burkholderia pseudomallei, Gastrointestinal tract, Melioidosis

Introduction

Melioidosis is an often fatal infectious disease caused by the Gram-negative bacillus Burkholderia pseudomallei, which is commonly found in soil and water in tropical countries.1 The disease is highly endemic in Southeast Asia and Northern Australia, and is increasingly reported from many other tropical regions, including South Asia, Africa, and Central and South America.1 A recent modeling study estimated that there are about 165 000 human melioidosis cases per year worldwide, of whom 89 000 (54%) die.1 Skin inoculation is considered to be the main route of infection, although there is increasing evidence to suggest that ingestion is an important route of human infection.2,3

In experimental mouse models, B. pseudomallei ingestion produces an effective infection, is associated with colonization of the stomach, results in acute or chronic disease depending on inoculating dose, and may lead to gut carriage and shedding in the stool for weeks after inoculation.4,5B. pseudomallei can be isolated from rectal swabs during acute human infection,6,7 which are routinely collected from patients with suspected melioidosis in Australia.8 However, it is not known whether humans with melioidosis develop gut colonization and shed B. pseudomallei in the stool. Furthermore, B. pseudomallei is likely to be frequently consumed in water and food in settings where the organism is present in the environment,2,3 and could colonize the gastrointestinal tract without clinical features or prior to the clinical presentation of melioidosis. A recent study conducted in Malaysia reported the isolation of B. pseudomallei from gastric biopsy samples in 15 of 215 (7%) patients who had gastric biopsy samples tested for Helicobacter pylori.9

We previously conducted a prospective hospital-based 1:2 matched case-control study to investigate the activities of daily living associated with acquisition of melioidosis in Northeast Thailand.2 Here, we reported the prevalence of B. pseudomallei in feces and rectal swabs taken from patients with melioidosis and in feces of control patients. In addition, we investigated whether B. pseudomallei colonizes the stomach in humans without clinical signs and symptoms of melioidosis by culturing gastric biopsies taken from patients in Northeast Thailand.

Materials and methods

A total of 83 stools and 58 rectal swabs were obtained from 141 culture-confirmed melioidosis cases presenting to Sunpasitthiprasong Hospital, Ubon Ratchathani, Northeast Thailand, between July 2010 and December 2011.2 A single sample was taken from each case, with rectal swabs collected in cases who were critically ill. In parallel, 244 stool samples were collected from 244 patients who were admitted to the study hospital with non-infectious conditions during the same period (controls).2 We also collected 799 gastric biopsy samples from 395 patients who underwent endoscopy and gastric biopsy at the study hospital between June 2014 and December 2015. The majority (n=390, 99%) had two gastric samples, the remaining cases having either one sample (1 patient), three samples (4 patients) or six samples (1 patient).

Rectal swabs were inoculated onto Ashdown selective agar and then placed into CVC50 broth (trypticase soy broth with crystal violet at 5 mg/liter plus colistin at 50 mg/liter).8 For each stool sample, an applicator swab was used to collect a small amount of stool from the container and directly inoculated onto Ashdown agar, and around 5 g of stool was added to CVC50 broth. Gastric biopsy samples were inoculated into CVC50 broth. All broths were incubated at 37°C in air for 48 hours, after which 10 μl was sub-cultured onto Ashdown agar. All agar plates were incubated at 37°C in air and inspected visually for 4 days. Presumptive B. pseudomallei colonies were identified using established methodologies.8

Results and Discussion

B. pseudomallei was isolated from 9/83 (11%) stools and 9/58 (16%) rectal swabs from 141 patients with melioidosis, confirming that it is not uncommon for these patients to shed B. pseudomallei in stool. The median age of patients was 53 years (range 18–78 years), 91 (65%) were men, 123 (87%) were considered acute (defined as symptoms present for less than 2 months), and 28 (20%) died within 28 days of the admission date. B. pseudomallei was also isolated from blood (n=67; 48%), respiratory specimens (61; 43%), urine (n=25; 18%), pus (n=47; 33%), throat swab (n=55; 39%), swabs from skin lesioins (n=10; 7%) and synovial fluid (n=7; 5%). This observation highlights an important possible reservoir for the introduction of B. pseudomallei into non-endemic areas, and may explain the mechanism by which this bacterium became globally disseminated between 1650 and 1850.10 Duration of carriage is unknown, and it is not clear whether B. pseudomallei in stool and the rectal mucosa originated from primary gastrointestinal infection following ingestion or from secondary dissemination following inoculation or inhalation. It is also possible that B. pseudomallei simply passed through the gastrointestinal tract after patients swallowed sputum or drank contaminated water.

All stools from 244 controls with non-infectious diseases and 799 gastric biopsies from 395 patients with no clinical evidence of melioidosis were culture negative for B. pseudomallei. This fails to replicate previous findings of positive gastric biopsies in people residing in a region where melioidosis is endemic,9 and indicates that B. pseudomallei colonization of the gut of individuals without signs and symptoms of melioidosis is rare in Northeast Thailand despite frequent ingestion.2,3 Further studies are needed to evaluate the presence of B. pseudomallei in drinking water, food and the human stomach in Kuala Lumpur and elsewhere in Malaysia.

Acknowledgments

Authors’ contributions: PT, SJP and DL conceived the study and designed the study protocol; PT, WK, SC, GW and VW carried out the data collection and assessment; PT and DL carried out analysis and interpretation of these data. PT, SJP and DL wrote the manuscript. All authors contributed to revising the draft, and read and approved the final manuscript. DL is guarantor of the paper.

Acknowledgements: We thank patients and staff of Sunpasitthiprasong Hospital, and the Mahidol-Oxford Tropical Medicine Research Programme. We thank Areeya Faosop, Sujittra Ngamwilai, Yaoewaret Dokket, Sukhumal Pewla-orng, Maliwan Hongsuwan, Suparinya Hanvongsa, Duangporn Narin, Varinthorn Praikaew, Jittana Suwannapruk, and Wilai Kamprom for their technical assistance.

Funding: This work was supported by the Wellcome Trust (090219/Z/09/Z and 106698/B/14/Z). DL is supported by the intermediate fellowship of the Wellcome Trust (101103/Z/13/Z).

Competing interests: None declared.

Ethical approval: The study was approved by Oxford Tropical Research Ethics Committee, and by the research ethics committees of Sunpasitthiprasong Hospital and the Faculty of Tropical Medicine, Mahidol University. Written informed consent was obtained from all participants.

References

  • 1. Limmathurotsakul D, Golding N, Dance DA et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016;1:15008. [DOI] [PubMed] [Google Scholar]
  • 2. Limmathurotsakul D, Kanoksil M, Wuthiekanun V et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 2013;7(2):e2072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Limmathurotsakul D, Wongsuvan G, Aanensen D et al. Melioidosis caused by Burkholderia pseudomallei in drinking water, Thailand, 2012. Emerg Infect Dis 2014;20(2):265–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. West TE, Myers ND, Limmathurotsakul D et al. Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice. Am J Trop Med Hyg 2010;83(5):1066–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Goodyear A, Bielefeldt-Ohmann H, Schweizer H et al. Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS One 2012;7(5):e37324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Wuthiekanun V, Dance DA, Wattanagoon Y et al. The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice. J Med Microbiol 1990;33(2):121–6. [DOI] [PubMed] [Google Scholar]
  • 7. Walsh AL, Wuthiekanun V, Smith MD et al. Selective broths for the isolation of Pseudomonas pseudomallei from clinical samples. Trans R Soc Trop Med Hyg 1995;89(1):124. [DOI] [PubMed] [Google Scholar]
  • 8. Hoffmaster AR, AuCoin D, Baccam P et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis 2015;21(2). https://wwwnc.cdc.gov/eid/article/21/2/14-1045_article [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Khosravi Y, Dieye Y, Poh BH et al. Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients. Scientific World Journal 2014;2014:610421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Chewapreecha C, Holden MT, Vehkala M et al. Global and regional dissemination and evolution of Burkholderia pseudomallei. Nat Microbiol 2017;2:16263. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Transactions of the Royal Society of Tropical Medicine and Hygiene are provided here courtesy of Oxford University Press

RESOURCES